Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Revenue

In the fiscal year ending March 31, 2026, Eris Lifesciences had annual revenue of 31.15B INR with 8.18% growth. Eris Lifesciences had revenue of 7.52B in the quarter ending March 31, 2026, with 7.07% growth.

• Revenue: 31.15B
• Revenue Growth: +8.18%
• P/S Ratio: 6.13
• Revenue / Employee: 9.29M
• Employees: 3,354
• Market Cap: 191.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	31.15B	2.36B	8.18%
Mar 31, 2025	28.79B	8.88B	44.59%
Mar 31, 2024	19.91B	3.29B	19.83%
Mar 31, 2023	16.62B	3.36B	25.31%
Mar 31, 2022	13.26B	1.34B	11.20%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error